1887

Abstract

Virus-neutralizing activity of two monoclonal antibodies (mAbs), #7-1-9 and #1-46-12, against rabies virus glycoprotein (G) was compared. Although these mAbs affected the virion’s ability to bind to host cells similarly, a big difference was found in the titres of virus neutralization (1:7132 and 1:32 for mAbs #1-46-12 and #7-1-9, respectively, at a concentration of 10 μg protein/ml). Although no big difference in virion-binding affinity between the two mAbs was found, the number of antibodies required for virus neutralization was very low, ⩽20 molecules for mAb #1-46-12 and ⩾250 molecules for mAb #7-1-9. In the latter case, the mAbs cover a major part of the virion surface and cause steric hindrance of viral receptor-binding activity. The infectivity of an epitope-preserved escape mutant virus (R-61) was not affected by the binding of high numbers of mAb #1-46-12 to the virion, which implies that mAb binding does not mask the receptor-binding site of the viral spikes. Based on these results, it is hypothesized that mAb #1-46-12 affected virus infectivity by a mechanism different from covering the virion spikes. Possible virus-neutralizing mechanisms by low numbers of mAb #1-46-12 in comparison to that of mAb #7-1-9 are discussed.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-83-12-3045
2002-12-01
2020-01-22
Loading full text...

Full text loading...

/deliver/fulltext/jgv/83/12/0833045a.html?itemId=/content/journal/jgv/10.1099/0022-1317-83-12-3045&mimeType=html&fmt=ahah

References

  1. Anzai, J., Takamatsu, F., Takeuchi, K., Kohno, T., Morimoto, K., Goto, H., Minamoto, N. & Kawai, A. ( 1997; ). Identification of a phosphatase-sensitive epitope of rabies virus nucleoprotein which is recognized by a monoclonal antibody 5-2-26. Microbiology and Immunology 41, 229-240.[CrossRef]
    [Google Scholar]
  2. Barroso, I. & Santisteban, P. ( 1999; ). Insulin-induced early growth response gene (Egr-1) mediates a short term repression of rat malic enzyme gene transcription. Journal of Biological Chemistry 247, 17997-18004.
    [Google Scholar]
  3. Burton, D. R., Saphire, E. O. & Parren, P. W. H. I. ( 2001; ). A model for neutralization of viruses based on antibody coating of the virion surface. Current Topics in Microbiology and Immunology 260, 109-143.
    [Google Scholar]
  4. Coll, J. M. ( 1995; ). The glycoprotein G of rhabdoviruses. Archives of Virology 140, 827-851.[CrossRef]
    [Google Scholar]
  5. Colonno, R. J., Callahan, P. L., Leippe, D. M., Rueckert, R. R. & Tomassini, J. E. ( 1989; ). Inhibition of rhinovirus attachment by neutralizing monoclonal antibodies and their Fab fragments. Journal of Virology 63, 36-42.
    [Google Scholar]
  6. Coulon, P., Rollin, P. E. & Flamand, A. ( 1982; ). Molecular basis of rabies virus virulence. II. Identification of a site on the CVS glycoprotein associated with virulence. Journal of General Virology 64, 693-696.
    [Google Scholar]
  7. Coulon, P., Rollin, P. E., Aubert, M. & Flamand, A. ( 1983; ). Molecular basis of rabies virus virulence. I. Selection of avirulent mutants of the CVS strain with anti-G monoclonal antibodies. Journal of General Virology 61, 97-100.
    [Google Scholar]
  8. Dietzschold, B., Cox, J. H. & Schneider, L. G. ( 1979; ). Rabies virus strains: a comparison study by polypeptide analysis of vaccine strains with different pathogenic patterns. Virology 98, 63-75.[CrossRef]
    [Google Scholar]
  9. Dietzschold, B., Wunner, W. H., Wiktor, T. J., Lopes, A. D., Lafon, M., Smith, C. L. & Koprowski, H. ( 1983; ). Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus. Proceedings of the National Academy of Sciences, USA 80, 70-74.[CrossRef]
    [Google Scholar]
  10. Dietzschold, B., Rupprecht, C. E., Tollis, M., Lafon, M., Mattei, J., Wiktor, T. J. & Koprowski, H. ( 1988; ). Antigenic diversity of the glycoprotein and nucleocapsid protein of rabies and rabies-related viruses: implications for epidemiology and control of rabies. Reviews of Infectious Diseases 10 (Suppl. 4), 785–798.
    [Google Scholar]
  11. Dietzschold, B., Gore, M., Marchadier, D., Niu, H. S., Bunschoten, H. M., Otvos, L.Jr, Wunner, W. H., Ertl, H. C., Osterhaus, A. D. M. E. & Koprowski, H. ( 1990; ). Structural and immunological characterization of a linear virus-neutralizing epitope of the rabies virus glycoprotein and its possible use in a synthetic vaccine. Journal of Virology 64, 3804-3809.
    [Google Scholar]
  12. Flamand, A., Wiktor, T. J. & Koprowski, H. ( 1980; ). Use of hybridoma monoclonal antibodies in the detection of antigenic differences between rabies and rabies-related virus proteins. II. The glycoprotein. Journal of General Virology 48, 105-109.[CrossRef]
    [Google Scholar]
  13. Flamand, A., Raux, H., Gaudin, Y. & Ruigrok, R. W. ( 1993; ). Mechanism of rabies virus neutralization. Virology 194, 302-313.[CrossRef]
    [Google Scholar]
  14. Hirai, K., Kawano, H., Mifune, K., Fujii, H., Nishizono, A., Shichijo, A. & Mannen, K. ( 1992; ). Suppression of cell-mediated immunity by street rabies virus infection. Microbiology and Immunology 36, 1277-1290.[CrossRef]
    [Google Scholar]
  15. Irie, T., Matsuda, Y., Honda, Y., Morimoto, K. & Kawai, A. ( 2002; ). Studies on the escape mutants of rabies virus which are resistant to the neutralization by a highly conserved conformational epitope-specific monoclonal antibody #1-46-12. Microbiology and Immunology 47, 449-461.
    [Google Scholar]
  16. Kawai, A. ( 1977; ). Transcriptase activity associated with rabies virion. Journal of Virology 24, 826-835.
    [Google Scholar]
  17. Kawai, A. & Takeuchi, K. ( 1992; ). Temperature-sensitivity of the replication of rabies virus (HEP-Flury strain) in BHK-21 cells. I. Alteration of viral RNA synthesis at the elevated temperature. Virology 186, 524-532.[CrossRef]
    [Google Scholar]
  18. Kawai, A. & Morimoto, K. ( 1994; ). Functional aspects of lyssavirus proteins. Current Topics in Microbiology and Immunology 187, 27-42.
    [Google Scholar]
  19. Kawai, A., Anzai, J., Honda, Y., Morimoto, K., Takeuchi, K., Kohno, T., Wakisaka, K., Goto, H. & Minamoto, N. ( 1997; ). Monoclonal antibody #5-2-26 recognizes the phosphatase-sensitive epitope of rabies virus nucleoprotein. Microbiology and Immunology 41, 33-42.[CrossRef]
    [Google Scholar]
  20. Lafon, M. ( 1994; ). Immunobiology of lyssaviruses: the basis for immunoprotection. Current Topics in Microbiology and Immunology 187, 145-160.
    [Google Scholar]
  21. Lafon, M., Wiktor, T. J. & Macfarlan, R. I. ( 1983; ). Antigenic sites on the CVS rabies virus glycoprotein: analysis with monoclonal antibodies. Journal of General Virology 64, 843-851.[CrossRef]
    [Google Scholar]
  22. Louie, R. E., Dobkin, M. B., Meyer, P., Chin, B., Roby, R. E., Hammar, A. H. & Cabasso, V. J. ( 1975; ). Measurement of rabies antibody: comparison of the mouse neutralization test (MNT) with the rapid fluorescent focus inhibition test (RFFIT). Journal of Biological Standardization 3, 365-373.[CrossRef]
    [Google Scholar]
  23. Morimoto, K., Kawai, A. & Mifune, K. ( 1992; ). Comparison of rabies virus G proteins produced by cDNA-transfected animal cells that display either inducible or constitutive expression of the gene. Journal of General Virology 73, 335-345.[CrossRef]
    [Google Scholar]
  24. Nakahara, K., Ohnuma, H., Sugita, S., Yasuoka, K., Nakahara, T., Tochikura, T. S. & Kawai, A. ( 1999; ). Intracellular behavior of rabies virus matrix protein (M) is determined by the viral glycoprotein (G). Microbiology and Immunology 43, 259-270.[CrossRef]
    [Google Scholar]
  25. Ni, Y., Tominaga, Y., Honda, Y., Morimoto, K., Sakamoto, S. & Kawai, A. ( 1995; ). Mapping and characterization of a sequential epitope on the rabies virus glycoprotein which is recognized by a neutralizing monoclonal antibody, RG719. Microbiology and Immunology 39, 693-702.[CrossRef]
    [Google Scholar]
  26. Perrin, P., Tino de Franco, M., Jallet, C., Fouque, F., Morgeaux, S., Tordo, N. & Colle, J. H. ( 1996; ). The antigen-specific cell-mediated immune response in mice is suppressed by infection with pathogenic lyssaviruses. Research in Virology 147, 289-299.[CrossRef]
    [Google Scholar]
  27. Possee, R. D., Schild, G. C. & Dimmock, N. J. ( 1982; ). Studies on the mechanism of neutralization of influenza virus by antibody: evidence that neutralizing antibody (anti-haemagglutinin) inactivates influenza virus in vivo by inhibiting virion transcriptase activity. Journal of Virology 58, 373-386.
    [Google Scholar]
  28. Prehaud, C., Coulon, P., LaFay, F., Thiers, C. & Flamand, A. ( 1988; ). Antigenic site II of the rabies virus glycoprotein: structure and role in viral virulence. Journal of Virology 62, 1-7.
    [Google Scholar]
  29. Rando, R. F. & Notkins, A. L. ( 1994; ). Production of human monoclonal antibodies against rabies virus. Current Topics in Microbiology and Immunology 187, 195-205.
    [Google Scholar]
  30. Sakamoto, S., Ide, T., Nakatake, H., Tokiyoshi, S., Yamamoto, M., Kawai, A. & Smith, J. S. ( 1994; ). Studies on the antigenicity and nucleotide sequence of the rabies virus Nishigahara strain, a current seed strain used for dog vaccine production in Japan. Virus Genes 8, 35-46.[CrossRef]
    [Google Scholar]
  31. Seif, I., Coulon, P., Rollin, P. E. & Flamand, A. ( 1985; ). Rabies virulence: effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoprotein. Journal of Virology 53, 926-934.
    [Google Scholar]
  32. Thraenhart, O., Marcus, I. & Kreuzfelder, E. ( 1994; ). Current and future immunoprophylaxis against human rabies: reduction of treatment failures and errors. Current Topics in Microbiology and Immunology 187, 173-194.
    [Google Scholar]
  33. Wiktor, T. J., Gyorgy, E., Schlumberger, D., Sokol, F. & Koprowski, H. ( 1973; ). Antigenic properties of rabies virus components. Journal of Immunology 110, 269-276.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-83-12-3045
Loading
/content/journal/jgv/10.1099/0022-1317-83-12-3045
Loading

Data & Media loading...

Most cited articles

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error